English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Meet Dr Vasile Musteata, 2022 iCMLf Prize Nominee
It’s a pleasure to share our second featured nominee for the iCMLf Prize in 2022, Dr Vasile Musteata, State Medical and Pharmaceutical University, Moldova.
Dr Musteata is an associate professor and hemato-oncologist, EACR ambassador, iCMLf representative for Moldova and also participates in research for the European LeukemiaNet Institution. Dr Musteata’s research and knowledge has been published in more than 150 articles and abstracts, and 10-years ago in 2012, he successfully completed the ERSAP Preceptorship Program in hematologic malignancies at MD Anderson Cancer Center, Texas, USA.
An update on the iCMLf’s Genomics and TFR Alliances
We are pleased to share an update on the iCMLf’s Genomics and TFR Alliances. 2022 has been a great year of progress for them both:
ESH-iCMLf 2022 Conference starts this Friday - Meet the iCMLf
October 2022 - The 24th annual John Goldman Conference starts this Friday and we can’t wait to meet you there in person!
We are delighted to share that a sub-analysis of the iCMLf COVID-19 and CML CANDID data will be presented during a poster walk at the conference.
And we are very pleased that the iCMLf prize winners of the last few years will be awarded their medals in person at the conference and we look forward to the keynote lectures of the 2022 prize recipients.
Also come to visit us at the iCMLf booth to learn more about our programs, research alliances and campaigns.
And join us for the John Goldman Charity Fun Run on Sunday morning!
Let's run together for the 2022 John Goldman Fun Run. And you can join us virtually!
October 2022 - Do you need motivation to run a 5km track? And do you want to support the work of the iCMLf? Then it’s time to join us for our annual John Goldman Charity Fun Run.
This year we will run together again. And this year, anyone can be involved!
If you are coming to the John Goldman Conference on CML in October, join us for the first face-to-face run in two years on Sunday morning.
If you can’t attend the conference, you can do your own 5 km run and join the CML community virtually.
All funds raised through this charity run will help the iCMLf to support young scientists and physicians from the emerging regions.
Let’s run together for a good cause.
Don't miss 'Highlights of ESH-iCMLf 2022' on Oct 26th at 14.00 CEST
October 2022 - The 24th John Goldman Conference is just around the corner – again with an excellent scientific program and new, often unpublished data on CML. If you can’t attend the live program, or would like a recap after the conference, then join us to discuss clinical and biological highlights of the meeting during an iCMLf Conversation.
On Wednesday, October 26th at 14.00 Central European Summer Time, meeting co-chairs, Professor Jorge Cortes and Professor Daniela Krause, will provide an overview of the significant clinical and biological aspects presented during the conference. There will also be plenty of time for your questions and an open discussion.
Don’t miss this opportunity and save the date.
Meet Dr Ali Bazarbachi One of This Year's iCMLf Prize Nominees
The first featured iCMLf Prize nominee is Dr Ali Bazarbachi, American University of Beirut, Lebanon
“CML is predicted to become the most prevalent leukemia by 2040 and accordingly an intensive global effort with more international collaborations between clinicians and researchers is imperative to find a definitive cure for CML.”
Ali Bazarbachi, MD, PhD is a Professor of Medicine (Hematology and Oncology), Professor of Anatomy, Cell Biology and Physiological Sciences, and Director of the bone marrow transplantation program at the American University of Beirut-Medical Center.
